Skip to main content

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) Investor Securities Class Action Lawsuit 01/07/2025

  • If you purchased a significant amount of shares of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) between November 2, 2023 and October 30, 2024, and / or if you purchased any NASDAQ: REGN shares prior to November 2023 and continue to hold any of those shares, you have certain options and for certain investors are short and strict deadlines running. Deadline: March 10, 2025. NASDAQ: REGN investors should contact the Shareholders Foundation, Inc

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

January 07, 2025 - An investor in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) filed a lawsuit in the U.S. District Court for the Southern District of New York over alleged violations of Federal Securities Laws by Regeneron Pharmaceuticals, Inc. in connection with certain allegedly false and misleading statements made between November 2, 2023 and October 30, 2024. Tarrytow...



You must register (for free) or login to view the entire case.